TBC1D13 Human

TBC1 Domain Family, Member 13 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Introduction to TBC1D13

TBC1 domain family member 13 (TBC1D13) is a GTPase-activating protein (GAP) primarily functioning as a regulator of Rab35, a small GTPase involved in membrane trafficking pathways. Discovered through functional screens in adipocytes, TBC1D13 has emerged as a critical modulator of insulin-stimulated glucose transporter type 4 (GLUT4) translocation to the plasma membrane (PM), a key process in glucose metabolism .

Domain Architecture

TBC1D13 contains a TBC domain spanning residues 32–400, essential for its GAP activity. This domain interacts with Rab35 in a nucleotide-dependent manner, accelerating GTP hydrolysis to regulate its activity .

Subcellular Localization

In adipocytes, TBC1D13 is distributed across cytosolic (70–80%) and membrane-bound (20–30%) fractions, with no significant redistribution upon insulin stimulation . It localizes to perinuclear regions and punctate structures, partially overlapping with GLUT4-containing vesicles .

FractionLocalizationInsulin EffectSource
Cytosol70–80%No change
Membranes (HDM/LDM)20–30%No change

Rab Interaction Specificity

TBC1D13 binds GTP-loaded Rab1 and Rab10 via yeast two-hybrid assays but exhibits GAP activity in vitro and in vivo exclusively toward Rab35 . Its specificity is confirmed by a library screen showing no activity against other Rab subfamilies .

Mechanism of Action

TBC1D13 inhibits insulin-stimulated GLUT4 translocation when overexpressed in adipocytes, an effect reversed by constitutively active Rab35 but not Rab10 . This suggests a Rab35-dependent trafficking step downstream of insulin signaling.

Key Experimental Findings

StudyObservationSource
Overexpression in adipocytes60% reduction in GTP-bound Rab35; inhibition of GLUT4 PM translocation
Yeast two-hybrid screenBinds Rab1 and Rab10 (GTP-dependent) but no GAP activity for these Rabs
Rescue experiment with Rab35Constitutively active Rab35 restores GLUT4 translocation in TBC1D13-overexpressing cells

Interaction Networks and Functional Partners

TBC1D13 interacts with proteins involved in membrane trafficking, metabolism, and mitosis, as revealed by proteomic and bioinformatics analyses .

ProteinInteraction ScoreFunctional RoleSource
Rab350.708GTPase activation, GLUT4 trafficking
SPOUT10.935Centrosome maturation, chromosome alignment
KYAT10.904Kynurenine transamination, detoxification

Other TBC1D family members (e.g., TBC1D10A, TBC1D10B) share functional overlaps in Rab regulation but exhibit distinct substrate specificities .

Tissue and Developmental Expression

TBC1D13 is highly expressed in adipocytes, with levels increasing during differentiation. It is the third most abundant RabGAP in 3T3-L1 adipocytes, surpassing AS160/TBC1D4 (a known GLUT4 regulator) .

Chemical Modulators

Environmental and pharmacological agents alter TBC1D13 expression:

ChemicalEffect on ExpressionModelSource
Bisphenol ADecreasedHuman
Cadmium dichlorideDecreased (mRNA)Human
All-trans-retinoic acidIncreased (mRNA)Human

Clinical and Pathological Relevance

While TBC1D13 itself is not directly implicated in cancer, TBC1D family members (e.g., TBC1D7) are overexpressed in triple-negative breast cancer (TNBC), linking RabGAP activity to metabolic reprogramming and disease aggressiveness . Further studies are needed to explore TBC1D13’s role in metabolic disorders or cancer.

In Vitro GAP Activity

TBC1D13 accelerates Rab35 GTP hydrolysis with a specificity constant (kcat/Kmk_{cat}/K_m) of 400±20M1s1400 \pm 20 \, \text{M}^{-1}\text{s}^{-1}, confirming its enzymatic role .

Trafficking Pathway Specificity

Overexpression does not disrupt ER-to-Golgi or endocytic trafficking, highlighting its specificity for GLUT4 recycling . Insulin signaling (e.g., Akt phosphorylation) remains intact, underscoring a late-stage trafficking defect .

Product Specs

Introduction
TBC1 Domain Family, Member 13, also known as TBC1D13, is a protein that contains a Rab-GAP TBC domain. It functions as a GTPase-activating protein for the Rab family of proteins.
Description
Recombinant human TBC1D13 protein was produced in E. coli. This protein is a single, non-glycosylated polypeptide chain consisting of 423 amino acids (residues 1-400) and has a molecular weight of 48.9 kDa. The TBC1D13 protein has a 23 amino acid His-tag fused at the N-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless, and sterile-filtered solution.
Formulation
The TBC1D13 solution is provided at a concentration of 1 mg/ml and contains 20 mM Tris-HCl buffer (pH 8.0), 0.15 M NaCl, 10% glycerol, and 1 mM DTT.
Stability
For short-term storage (up to 2-4 weeks), the TBC1D13 solution should be stored at 4°C. For long-term storage, it is recommended to store the protein at -20°C. Adding a carrier protein such as 0.1% HSA or BSA is recommended for long-term storage. Repeated freezing and thawing of the protein should be avoided.
Purity
The purity of the TBC1D13 protein is greater than 95% as determined by SDS-PAGE analysis.
Synonyms
RP11-545E17.5, TBC1 domain family member 13, Tumor Suppressor Candidate 2, TBC1D13.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMSSLHKS RIADFQDVLK EPSIALEKLR ELSFSGIPCE GGLRCLCWKI LLNYLPLERA SWTSILAKQR ELYAQFLREM IIQPGIAKAN MGVSREDVTF EDHPLNPNPD SRWNTYFKDN EVLLQIDKDV RRLCPDISFF QRATDYPCLL ILDPQNEFET LRKRVEQTTL KSQTVARNRS GVTNMSSPHK NSVPSSLNEY EVLPNGCEAH WEVVERILFI YAKLNPGIAY VQGMNEIVGP LYYTFATDPN SEWKEHAEAD TFFCFTNLMA EIRDNFIKSL DDSQCGITYK MEKVYSTLKD KDVELYLKLQ EQNIKPQFFA FRWLTLLLSQ EFLLPDVIRI WDSLFADDNR FDFLLLVCCA MLMLIREQLL EGDFTVNMRL LQDYPITDVC QILQKAKELQ DSK.

Q&A

How does TBC1D13 gene structure compare in humans versus other species?

The gene structure of TBC1D13 appears to be conserved across mammalian species, though with some variations. In the western European hedgehog (Erinaceus europaeus), TBC1D13 has multiple isoforms, including three documented variants: isoform X1, X2, and X3 . The nucleotide sequence length of hedgehog TBC1D13 is 1203bp .

While the search results don't provide specific comparative data for humans, researchers should note that unlike TBC1D3 (which shows dramatic lineage-specific expansion in primates with copy number variations from 1-14 copies in humans ), TBC1D13 appears to have maintained a more consistent gene structure across evolutionary time.

Methodological approach for comparative genomics:

  • Perform multiple sequence alignments across species using tools like MUSCLE or CLUSTALW

  • Generate phylogenetic trees to visualize evolutionary relationships

  • Analyze synteny to identify conserved gene neighborhoods

  • Examine selection pressure using dN/dS ratios

What expression patterns does TBC1D13 exhibit across human tissues?

While the provided search results don't contain specific expression data for TBC1D13 in humans, researchers can utilize methodological approaches to characterize its expression:

  • RNA-seq analysis across tissue panels

  • Single-cell transcriptomics to identify cell-type specific expression

  • Quantitative PCR validation of expression in tissues of interest

  • Antibody-based approaches including Western blotting and immunohistochemistry

For context, the related gene TBC1D3 shows modest global expression with increased levels in testis and brain tissue according to GTEx data . Researchers investigating TBC1D13 should establish tissue-specific expression profiles as a foundation for functional studies.

How can researchers distinguish between TBC1D13 and other TBC domain family members in experimental settings?

The TBC domain family includes numerous members with similar structural features, creating challenges for specific detection and functional analysis. This is particularly relevant when studying TBC1D13 in relation to TBC1D3, which has undergone significant expansion in primates .

Methodological approach for specific detection:

  • Target unique epitopes for antibody generation

    • Design peptides corresponding to regions with lowest sequence similarity

    • Validate antibody specificity against recombinant proteins of multiple TBC family members

  • Design highly specific nucleic acid detection methods

    • Create primers targeting unique exon junctions

    • Employ droplet digital PCR for absolute quantification

    • Use RNA-FISH with highly specific probes for spatial localization

  • CRISPR-based tagging systems

    • Insert epitope tags or fluorescent proteins at endogenous loci

    • Employ degron-based approaches for temporal control of protein levels

  • Mass spectrometry identification

    • Identify unique peptide signatures that distinguish between family members

    • Use parallel reaction monitoring for targeted protein quantification

What are the optimal experimental systems for studying TBC1D13 function?

Based on what we know about TBC domain proteins and their roles in membrane trafficking, several experimental systems can be employed:

Experimental SystemAdvantagesLimitationsBest Applications
HeLa or HEK293 cell linesEasy transfection, well-characterizedMay not represent tissue-specific functionsInitial characterization, protein-protein interactions
Neuronal cell lines (SH-SY5Y)More relevant for potential neuronal functionsMore difficult to manipulateNeuron-specific trafficking events
iPSC-derived organoidsPhysiological 3D contextTechnical complexity, variabilityDevelopmental studies, tissue-specific functions
Mouse modelsIn vivo relevanceSpecies differences, time-consumingPhysiological relevance, developmental roles

Methodological recommendations:

  • Begin with well-characterized cell lines for basic localization and interaction studies

  • Proceed to more specialized systems based on expression data

  • Consider conditional knockout approaches to avoid developmental compensation effects

  • Employ live-cell imaging with fluorescently tagged constructs to monitor dynamic processes

How might evolutionary analysis inform TBC1D13 functional studies?

Unlike TBC1D3, which has undergone significant lineage-specific expansions in primates with independent duplications in at least five primate lineages , TBC1D13 appears more evolutionarily conserved. This evolutionary context provides important insights for functional studies.

Methodological approach for evolutionary analysis:

  • Perform detailed phylogenetic analysis across species

  • Compare selection signatures between TBC1D13 and expanded families like TBC1D3

  • Analyze syntenic regions to identify potential co-evolutionary patterns

  • Examine conservation of protein domains and regulatory elements

The research on TBC1D3 shows that despite having multiple duplications, only specific paralogs (particularly TBC1D3-CDKL) show significant expression . Similar paralog-specific expression patterns could exist for TBC1D13 and should be investigated.

What are the technical challenges in analyzing potential TBC1D13 genetic variants in human populations?

Studying genetic variants in TBC1D13 presents several technical challenges that researchers should address:

  • Primer design and sequencing challenges

    • Presence of pseudogenes or related family members can complicate specific amplification

    • High GC content regions may require specialized PCR conditions

  • Copy number variation analysis

    • If TBC1D13 exhibits copy number variations like TBC1D3, specialized approaches are needed

    • Long-read sequencing technologies (PacBio, Oxford Nanopore) are recommended for resolving complex structural variants

  • Variant interpretation

    • Distinguishing pathogenic from benign variants requires multiple lines of evidence

    • Functional validation in cellular models is essential for variant classification

  • Population frequency assessment

    • Check representation in diverse population databases

    • Consider potential population-specific effects

Methodological recommendations include using a combination of short and long-read sequencing technologies, coupled with computational approaches that can account for sequence similarities within gene families.

What protein interaction studies best characterize TBC1D13's functional network?

Understanding TBC1D13's protein interaction network is crucial for elucidating its function. Several complementary approaches should be employed:

  • Proximity-dependent biotin labeling (BioID or TurboID)

    • Tags TBC1D13 with a biotin ligase to label proximal proteins

    • Identifies both stable and transient interactions in living cells

    • Can be targeted to specific subcellular compartments

  • Affinity purification mass spectrometry (AP-MS)

    • More suitable for stable interactions

    • Can identify protein complexes

    • Use both N- and C-terminal tags to avoid interference with function

  • Yeast two-hybrid screening

    • Tests for direct binary interactions

    • Can identify novel binding partners

    • Requires validation in mammalian systems

  • Co-immunoprecipitation with specific Rab GTPases

    • Tests specific hypotheses about TBC1D13's GAP activity

    • Measures interaction under different nucleotide-binding states

    • Can be coupled with activity assays

For data analysis, compare interactomes to other TBC domain proteins to identify both shared and unique interaction partners. This approach has proven valuable in characterizing other TBC family members and would likely yield insights into TBC1D13's specific cellular roles.

How can researchers effectively study the role of TBC1D13 in cellular trafficking pathways?

As a putative Rab GAP protein, TBC1D13 likely regulates specific steps in membrane trafficking. To characterize these functions:

  • Fluorescent cargo trafficking assays

    • Track movement of fluorescently labeled cargo proteins

    • Measure kinetics of internalization, recycling, or degradation

    • Quantify colocalization with compartment markers

  • Live-cell imaging approaches

    • Use fluorescently tagged TBC1D13 to monitor dynamic localization

    • Employ photoactivatable or photoconvertible tags for pulse-chase analysis

    • Implement super-resolution microscopy for detailed localization

  • In vitro GAP activity assays

    • Test GAP activity against panel of purified Rab proteins

    • Measure GTP hydrolysis rates using fluorescent or radioactive nucleotides

    • Identify key catalytic residues through structure-guided mutagenesis

  • Computational prediction and validation

    • Use structural modeling to predict Rab specificity

    • Validate predictions experimentally

    • Model how variants might affect GAP activity

These approaches should be implemented in both gain- and loss-of-function experimental designs to comprehensively characterize TBC1D13's role in trafficking pathways.

How might single-cell approaches advance our understanding of TBC1D13 function?

Single-cell technologies offer unprecedented resolution for studying gene function and can address several questions about TBC1D13:

  • Single-cell RNA sequencing applications:

    • Identify cell populations with highest TBC1D13 expression

    • Detect co-expression patterns to infer functional relationships

    • Track expression changes during development or disease progression

  • Spatial transcriptomics approaches:

    • Map TBC1D13 expression within tissue architecture

    • Correlate with cell type markers and functional zones

    • Identify potential region-specific functions

  • Single-cell proteomics:

    • Quantify TBC1D13 protein levels at single-cell resolution

    • Correlate with pathway activation markers

    • Detect post-translational modifications

  • Integrative analysis:

    • Combine transcriptomic and proteomic data

    • Develop predictive models of TBC1D13 function

    • Identify cell state-specific roles

These approaches provide critical context for interpreting functional studies and may reveal unexpected cell type-specific functions that would be missed in bulk analysis.

What comparative insights might be gained by studying TBC1D13 versus the expanded TBC1D3 gene family?

Comparing TBC1D13 with the expanded TBC1D3 gene family offers unique evolutionary and functional insights:

  • Evolutionary comparison points:

    • TBC1D3 shows lineage-specific expansion in primates with independent duplications in at least five primate lineages

    • TBC1D3 varies from 1-14 copies in humans with high structural variability

    • TBC1D3 duplications are enriched at chromosomal rearrangement sites

  • Expression pattern differences:

    • Despite multiple duplications, TBC1D3 expression is primarily from a single paralog group (TBC1D3-CDKL)

    • This selective expression may represent a mechanism for maintaining critical functions despite high copy number variation

  • Methodological approaches for comparison:

    • Generate evolutionary models of domain conservation

    • Perform comparative functional assays in cellular models

    • Analyze promoter and regulatory element differences

    • Study differences in post-translational regulation

  • Implications for genetic studies:

    • Understanding how gene families maintain function despite structural variation

    • Insights into how new functions emerge from duplicated genes

    • Guidelines for interpreting copy number variations in clinical contexts

This comparative approach may reveal fundamental principles about the evolution of gene function and regulation that extend beyond these specific gene families.

Product Science Overview

Gene and Protein Information
  • Gene Symbol: TBC1D13
  • Protein Name: TBC1 Domain Family Member 13
  • Aliases: FLJ10743, Epididymis Secretory Sperm Binding Protein 3
  • UniProt ID: Q9NVG8
  • NCBI Gene ID: 54662
Function

TBC1D13 acts as a GTPase-activating protein (GAP) for Rab family proteins, specifically RAB35 . GTPase-activating proteins are crucial for the regulation of GTPases, which are involved in various cellular processes such as vesicle-mediated transport and intracellular protein trafficking . TBC1D13, in conjunction with RAB35, is implicated in the regulation of insulin-induced glucose transporter SLC2A4/GLUT4 translocation to the plasma membrane in adipocytes .

Pathways and Interactions

TBC1D13 is involved in several pathways, including:

  • Vesicle-mediated transport
  • Rab regulation of trafficking

These pathways are essential for maintaining cellular homeostasis and ensuring the proper functioning of intracellular transport mechanisms .

Clinical Significance

Mutations or dysregulation of TBC1D13 have been associated with certain diseases, including:

  • Tricuspid Valve Prolapse
  • Arterial Tortuosity Syndrome

These associations highlight the importance of TBC1D13 in maintaining normal physiological functions and its potential role in disease mechanisms .

Recombinant Protein

The recombinant form of TBC1D13 is produced in E. coli and is a single, non-glycosylated polypeptide chain containing 423 amino acids with a molecular mass of approximately 48.9 kDa . This recombinant protein is often used in research to study the function and interactions of TBC1D13 in various cellular processes .

Research Applications

The recombinant TBC1D13 protein is utilized in various research applications, including:

  • Blocking Assays: Used to block specific interactions in experimental setups.
  • Control Experiments: Acts as a control in various assays to ensure the specificity and accuracy of experimental results .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.